3/8/2013

U.S. diagnostics maker Saladax Biomedical secured a $22.4 million equity investment from Shanghai Fosun Pharmaceutical. Proceeds will go toward increasing the firm's product portfolio and launching its MyCare blood tests.

Related Summaries